Entity Common Stock, Shares Outstanding of Gain Therapeutics, Inc. from 30 Apr 2021 to 31 Oct 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Gain Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 30 Apr 2021 to 31 Oct 2025.
  • Gain Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 31 Oct 2025 was 36,097,536, a 36% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Gain Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 36,097,536 +9,572,468 +36% 31 Oct 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 35,948,606 +10,413,146 +41% 31 Jul 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 29,557,640 +11,505,661 +64% 30 Apr 2025 10-Q 14 May 2025 2025 Q1
Q3 2024 26,525,068 +13,614,726 +105% 31 Oct 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 25,535,460 +12,836,038 +101% 31 Jul 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 18,051,979 +5,723,133 +46% 30 Apr 2024 10-Q 14 May 2024 2024 Q1
Q3 2023 12,910,342 +1,026,974 +8.6% 31 Oct 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 12,699,422 +816,054 +6.9% 31 Jul 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 12,328,846 +445,478 +3.7% 30 Apr 2023 10-Q 12 May 2023 2023 Q1
Q3 2022 11,883,368 +3,625 +0.03% 31 Oct 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 11,883,368 +6,728 +0.06% 31 Jul 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 11,883,368 +6,728 +0.06% 29 Apr 2022 10-K/A 02 May 2022 2021 FY
Q3 2021 11,879,743 30 Oct 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 11,876,640 31 Jul 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 11,876,640 30 Apr 2021 10-Q 10 May 2021 2021 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.